Latest News for: mrna
Edit
S&P 500 Movers | Winners: CCI, MRNA, HUM | Losers: TMUS, T, VZ (Insight Guru Inc)
Public Technologies 10 Oct 2026
). The S&P 500 gained 0.6% on Friday, October 9, while the Nasdaq-100 rose 0.5% and the Dow Jones Industrial Average advanced 0.8% ... 2 MRNA Moderna 14.2% n/a ... Moderna (MRNA) added to a longer run ... 3 MRNA Moderna 18.4% n/a ... 1 MRNA Moderna 64.7% n/a.
Edit
GOP governor candidate Zach Lahn discusses mRNA vaccine policy in Iowa
Des Moines Register 09 Oct 2026
Republican candidate for Iowa governor Zach Lahn discusses his views on vaccines and public health policy. .
Edit
Morgan Citizen
09 Oct 2026
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
Edit
S&P 500 Movers | Winners: NRG, MRNA, MU | Losers: CAT, EME, CRWD (Insight Guru Inc)
Public Technologies 08 Oct 2026
). The S&P 500 slipped 0.2% on Wednesday, October 7, while the Nasdaq-100 dipped 0.2% and the Dow Jones Industrial Average fell 0.7% ... 2 MRNA Moderna 4.8% n/a ... The 4.8% gain in Moderna (MRNA) on Wednesday was not a one-off ... 3 MRNA Moderna 40.0% n/a.
Edit
Fired FDA drug chief questions mRNA flu shot approved after her ouster
Natural News 06 Oct 2026
Edit
Rutland Herald
06 Oct 2026
Sensible Biotechnologies Secures $47 Million to Advance Naturally Modified mRNA Platform and Unlock Next Generation ...
Edit
'Blood clots surge like never before…': Dr McCullough's chilling revelations on mRNA COVID vaccines
The Economic Times 06 Oct 2026
'Blood clots surge like never before…'. Dr McCullough's chilling revelations on mRNA COVID vaccines ... .
Edit
"Very concerning safety issues": Trump's mRNA-skeptic FDA drug chief was mysteriously fired - right before ...
Sott 06 Oct 2026
"I'm worried about approvals that we've seen recently, like the mRNA influenza vaccine," H�eg told journalist Paul Thacker in an interview posted Wednesday, citing "very concerning safety issues."
Edit
Hartford City News Times
03 Oct 2026
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other ...
Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager ... .
Edit
The Galveston Daily News
02 Oct 2026
Novartis signs mRNA deal for about $7.8 billion with China's Abogen
Edit
Moderna’s mRNA unlock (Eka Ventures LLP)
Public Technologies 02 Oct 2026
Following this, the standard of care from here is a year of immunotherapy ... [...]. This is an abstract of the document ... Attachments Original document Permalink. Disclaimer ... (noodl.
Edit
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs
PR Newswire 02 Oct 2026
Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager ... ABO2203 is a novel mRNA-encoded CD19xCD3 T-cell engager with the potential to transform the treatment landscape for patients with autoimmune diseases.
- 1
- 2
- Next page »